Understanding Pharmacopoeia and ACS Compliance
WEBINAR
In a pharmaceutical Quality Control (QC) laboratory, the use of specific reagents, such as inorganic chemicals, solvents, titration and Karl Fischer reagents, is essential to ensure compliance with the requirements set forth by pharmacopoeias, such as the European Pharmacopoeia (EP) and United States Pharmacopeia (USP).
By utilizing compliant reagents, you minimize the risk of contamination, variability, and errors in testing, thereby protecting patient safety and enhancing the integrity of pharmaceutical products.
Join us to explore the reagent requirements outlined by various pharmacopoeias and understand how they contribute to achieving reliable analytical results.
Speakers

Bettina Straub-Jubb
Merck
Global Product Manager, Karl Fischer Titration
Bettina is the global franchise product manager and lead expert for titration at Merck. She has more than 20 years’ experience in the instrumental analysis business, especially with Karl Fischer Titration, general Titration, Reference Materials and Diagnostics. Her responsibilities include improving and simplifying titration processes, drive new technologies and advancing applications and reagents.
She works always closely together with the QC and application laboratories for titration as well as with the R&D department to develop titration continuously. Bettina is a graduated engineer and holds a degree in Chemical Technology from the University of Applied Sciences, Darmstadt Germany and a degree as Medical Technical Laboratory Assistant from the Medical Technical Academy Esslingen, Germany.

Christian Roth
Merck
Senior Product Manager Inorganics
Christian Roth, brings over 25 years of experience managing a diverse portfolio of analytical purity products. With a degree in International Business Management, he combines technical expertise with global business strategies to deliver exceptional value to customers in analytical labs.
Analytical chemistry
- Titration and Karl Fischer titration
Duration:1h
Language:English
Session 1:Tue, April 28, 2026 9:00 AM CEST
Session 2:Tue, April 28, 2026 6:00 PM CEST
To continue reading please sign in or create an account.
Don't Have An Account?